Villitis of Unknown Etiology Is Associated with a Distinct Pattern of Chemokine Up-Regulation in the Feto-Maternal and Placental Compartments: Implications for Conjoint Maternal Allograft Rejection and Maternal Anti-Fetal Graft-versus-Host Disease
- 15 March 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 182 (6) , 3919-3927
- https://doi.org/10.4049/jimmunol.0803834
Abstract
The co-presence of histoincompatible fetal and maternal cells is a characteristic of human placental inflammation. Villitis of unknown etiology (VUE), a destructive inflammatory lesion of villous placenta, is characterized by participation of Hofbauer cells (placental macrophages) and maternal T cells. In contrast to acute chorioamnionitis of infection-related origin, the fundamental immunopathology of VUE is unknown. This study was performed to investigate the placental transcriptome of VUE and to determine whether VUE is associated with systemic maternal and/or fetal inflammatory response(s). Comparison of the transcriptome between term placentas without and with VUE revealed differential expression of 206 genes associated with pathways related to immune response. The mRNA expression of a subset of chemokines and their receptors (CXCL9, CXCL10, CXCL11, CXCL13, CCL4, CCL5, CXCR3, CCR5) was higher in VUE placentas than in normal placentas (p < 0.05). Analysis of blood cell mRNA showed a higher expression of CXCL9 and CXCL13 in the mother, and CXCL11 and CXCL13 in the fetus of VUE cases (p < 0.05). The median concentrations of CXCL9, CXCL10, and CXCL11 in maternal and fetal plasma were higher in VUE (p < 0.05). Comparison of preterm cases without and with acute chorioamnionitis revealed elevated CXCL9, CXCL10, CXCL11, and CXCL13 concentrations in fetal plasma (p < 0.05), but not in maternal plasma with chorioamnionitis. We report for the first time the placental transcriptome of VUE. A systemic derangement of CXC chemokines in maternal and fetal circulation distinguishes VUE from acute chorioamnionitis. We propose that VUE be a unique state combining maternal allograft rejection and maternal antifetal graft-vs-host disease mechanisms.Keywords
This publication has 58 references indexed in Scilit:
- A novel signaling pathway impact analysisBioinformatics, 2008
- Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiologyHistopathology, 2008
- CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantationBlood, 2007
- A systems biology approach for pathway level analysisGenome Research, 2007
- Genome Expression Pathway Analysis Tool – Analysis and visualization of microarray gene expression data under genomic, proteomic and metabolic contextBMC Bioinformatics, 2007
- Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression ProfilingAmerican Journal of Transplantation, 2005
- CXCR3 and CCR5 Positive T-Cell Recruitment in Acute Human Renal Allograft RejectionTransplantation, 2004
- The Chemokine CXCL13 (BCA-1) Inhibits FGF-2 Effects on Endothelial CellsBiochemical and Biophysical Research Communications, 2001
- Immunohistochemical Study of Skin Lesions in Acute and Chronic Graft Versus Host Disease Following Bone Marrow TransplantationThe American Journal of Surgical Pathology, 1997
- Maternal serum interleukin-6 concentrations in patients with preterm premature rupture of membranes and evidence of infectionAmerican Journal of Obstetrics and Gynecology, 1996